Patterns of CPAP usage in patients with minimally symptomatic OSA

Patterns of CPAP usage in patients with minimally symptomatic OSA

Detalhes bibliográficos
Main Authors:	Turnbull, C, Bratton, D, Craig, S, Kohler, M, Stradling, J
Formato:	Conference item
Idioma:	English
Publicado em:	European Respiratory Society 2015

Registos relacionados

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
Por: Turnbull, CD, et al.
Publicado em: (2016)

In minimally symptomatic OSA what is the best test to measure CPAP response?
Por: Turnbull, C, et al.
Publicado em: (2015)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
Por: Kohler, M, et al.
Publicado em: (2010)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
Por: Craig, S, et al.
Publicado em: (2014)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
Por: Kohler, M, et al.
Publicado em: (2013)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
Por: Craig, S, et al.
Publicado em: (2015)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Por: Tang, I, et al.
Publicado em: (2020)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Por: John R Stradling, et al.
Publicado em: (2020-09-01)

Predictors of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial.
Por: Turnbull, C, et al.
Publicado em: (2015)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
Por: Craig, SE, et al.
Publicado em: (2010)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
Por: Turnbull, C, et al.
Publicado em: (2016)

CPAP and measures of cardiovascular risk in males with OSAS.
Por: Kohler, M, et al.
Publicado em: (2008)

Residual sleepiness in patients with OSA on CPAP.
Por: Stradling, JR
Publicado em: (2009)

Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
Por: Bratton, D, et al.
Publicado em: (2014)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
Por: Petousi, N, et al.
Publicado em: (2018)

Predictors Of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial
Por: Turnbull, C, et al.
Publicado em: (2015)

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
Por: Antoniades, C, et al.
Publicado em: (2016)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
Por: Turnbull, CD, et al.
Publicado em: (2021)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
Por: Turnbull, C, et al.
Publicado em: (2015)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
Por: Stradling, JR, et al.
Publicado em: (2004)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
Por: Schwarz, E, et al.
Publicado em: (2016)

Mild To Moderate, Minimally Symptomatic, Obstructive Sleep Apnoea (OSA) Is Associated With 'Vulnerable' Carotid Atherosclerotic Plaques
Por: Craig, SE, et al.
Publicado em: (2010)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
Por: Lettau, F, et al.
Publicado em: (2017)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
Por: Schwarz, E, et al.
Publicado em: (2016)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
Por: Stradling, JR, et al.
Publicado em: (2004)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
Por: Proudlove, K, et al.
Publicado em: (2012)

ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Por: Schlatzer, C, et al.
Publicado em: (2016)

CPAP increases bronchial reactivity in OSAS patients
Por: P. Korczyski, et al.
Publicado em: (2008-06-01)

Effect of CPAP on depressive symptoms in OSA
Por: Samy S. Eldahdouh, et al.
Publicado em: (2014-04-01)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
Por: Robinson, G, et al.
Publicado em: (2007)

Does greater obesity alter the relationship between autoset continuous positive airways pressure (CPAP) and either obstructive sleep apnoea (OSA) severity or the obesity itself?
Por: Turnbull, C, et al.
Publicado em: (2015)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
Por: Craig, SE, et al.
Publicado em: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
Por: Craig, SE, et al.
Publicado em: (2012)

S3 Effect of continuous positive airway pressure on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials
Por: Bratton, D, et al.
Publicado em: (2013)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
Por: Warley, A, et al.
Publicado em: (1987)

Transcriptomic analysis identifies a unique, intermittent hypoxia mediated inflammatory profile: evidence from a cross-over randomised CPAP withdrawal trial, with and without supplemental oxygen, in OSA
Por: Turnbull, C, et al.
Publicado em: (2018)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
Por: Robinson, G, et al.
Publicado em: (2008)

Cardiovascular Risk in Asymptomatic OSA
Por: Kohler, M, et al.
Publicado em: (2009)

The Assessment of Endothelial Dysfunction among OSA Patients after CPAP Treatment
Por: Klaudia Brożyna-Tkaczyk, et al.
Publicado em: (2021-03-01)

The effects of supplemental oxygen on blood pressure in obstructive sleep apnoea during cpap withdrawal
Por: Turnbull, C, et al.
Publicado em: (2017)